000 02031 a2200565 4500
005 20250514075709.0
264 0 _c20030930
008 200309s 0 0 eng d
022 _a1524-4539
024 7 _a10.1161/01.CIR.0000087601.45803.86
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTcheng, James E
245 0 0 _aBenefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
_h[electronic resource]
260 _bCirculation
_cSep 2003
300 _a1316-23 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
650 0 4 _aAbciximab
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAngioplasty, Balloon, Coronary
650 0 4 _aAntibodies, Monoclonal
_xadverse effects
650 0 4 _aCombined Modality Therapy
650 0 4 _aCoronary Angiography
650 0 4 _aEndpoint Determination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunoglobulin Fab Fragments
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMyocardial Infarction
_xdiagnosis
650 0 4 _aPlatelet Aggregation Inhibitors
_xadverse effects
650 0 4 _aPlatelet Glycoprotein GPIIb-IIIa Complex
_xantagonists & inhibitors
650 0 4 _aStents
650 0 4 _aTreatment Outcome
700 1 _aKandzari, David E
700 1 _aGrines, Cindy L
700 1 _aCox, David A
700 1 _aEffron, Mark B
700 1 _aGarcia, Eulogio
700 1 _aGriffin, John J
700 1 _aGuagliumi, Giulio
700 1 _aStuckey, Thomas
700 1 _aTurco, Mark
700 1 _aFahy, Martin
700 1 _aLansky, Alexandra J
700 1 _aMehran, Roxana
700 1 _aStone, Gregg W
773 0 _tCirculation
_gvol. 108
_gno. 11
_gp. 1316-23
856 4 0 _uhttps://doi.org/10.1161/01.CIR.0000087601.45803.86
_zAvailable from publisher's website
999 _c12709367
_d12709367